INCY
NASDAQ · Biotechnology
Incyte Corp
$90.62
+0.17 (+0.19%)
Performance
1D
—
1W
—
1M
—
3M
-9.48%
6M
+9.58%
1Y
+45.97%
YTD
-10.65%
Open$89.63
Previous Close$90.45
Day High$91.70
Day Low$89.25
52W High$112.29
52W Low$53.56
Volume—
Avg Volume2.17M
Market Cap20.25B
P/E Ratio15.74
EPS$6.40
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$101.74
Below
SMA 200
$86.15
Above
RSI (14)
51.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
33 analysts
Price Target
+128.2% upside
Current
$90.62
$90.62
Target
$206.81
$206.81
$125.25
$206.81 avg
$260.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.78B | 4.17B | 3.83B |
| Net Income | 1.20B | 938.44M | -346,012,622 |
| Profit Margin | 25.0% | 23.8% | -9.0% |
| EBITDA | 1.46B | 1.21B | -409,317,505 |
| Free Cash Flow | — | — | -346,886,835 |
| Rev Growth | +14.8% | +14.8% | -9.6% |
| Debt/Equity | 0.01 | 0.01 | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |